As of 2024, there is no peer-reviewed clinical evidence demonstrating that commercially available GLP-1 patches deliver therapeutic outcomes comparable to FDA-approved GLP-1 medications
And while everyone taking a weight-loss medication should prioritize diet and exercise, it becomes even more important when youre microdosing
Accessing Retatrutide in Canada For Canadians interested in Retatrutide, understanding the current landscape is important
Usually, this is done by injecting it under the skin of the thigh, upper arm, or stomach
Retatrutide has only completed Phase 2 trials
Lead researcher Hamlet Gasoyan, DS, Ph.D., MPH, noted that patients treated for type 2 diabetes were more likely to restart treatment than those taking the drugs for obesity alone, likely because insurance coverage for these medications is currently broader for diabetes than for obesity